Atle Fund Management AB as of Dec. 31, 2025
Portfolio Holdings for Atle Fund Management AB
Atle Fund Management AB holds 39 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 10.7 | $34M | 31k | 1074.68 | |
| Abbvie (ABBV) | 7.9 | $25M | 108k | 228.49 | |
| Merck & Co (MRK) | 6.6 | $21M | 196k | 105.26 | |
| Thermo Fisher Scientific (TMO) | 5.5 | $17M | 30k | 579.45 | |
| Neurocrine Biosciences (NBIX) | 4.3 | $13M | 95k | 141.83 | |
| Intuitive Surgical Com New (ISRG) | 4.0 | $13M | 22k | 566.36 | |
| Beone Medicines Ltd- Sponsored Ads (ONC) | 3.9 | $12M | 40k | 303.81 | |
| Bridgebio Pharma (BBIO) | 3.4 | $11M | 141k | 76.49 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.3 | $10M | 23k | 453.36 | |
| Boston Scientific Corporation (BSX) | 3.3 | $10M | 109k | 95.35 | |
| Stryker Corporation (SYK) | 3.0 | $9.4M | 27k | 351.47 | |
| CVS Caremark Corporation (CVS) | 2.7 | $8.5M | 107k | 79.36 | |
| Krystal Biotech (KRYS) | 2.7 | $8.3M | 34k | 246.54 | |
| AmerisourceBergen (COR) | 2.6 | $8.0M | 24k | 337.75 | |
| Ionis Pharmaceuticals (IONS) | 2.3 | $7.3M | 92k | 79.11 | |
| Revolution Medicines (RVMD) | 2.3 | $7.2M | 90k | 79.65 | |
| Amgen (AMGN) | 2.3 | $7.2M | 22k | 327.31 | |
| Mirum Pharmaceuticals (MIRM) | 2.3 | $7.1M | 90k | 78.99 | |
| Incyte Corporation (INCY) | 2.2 | $7.0M | 71k | 98.77 | |
| NewAmsterdam Pharma Co NV Ordinary Shares (NAMS) | 2.2 | $6.9M | 197k | 35.08 | |
| Alkermes SHS (ALKS) | 2.2 | $6.8M | 243k | 27.98 | |
| Irhythm Technologies (IRTC) | 2.1 | $6.7M | 38k | 177.44 | |
| Gilead Sciences (GILD) | 2.0 | $6.2M | 51k | 122.74 | |
| UFP Technologies (UFPT) | 1.6 | $5.1M | 23k | 222.03 | |
| Insmed Com Par $.01 (INSM) | 1.5 | $4.9M | 28k | 174.04 | |
| Cardinal Health (CAH) | 1.5 | $4.8M | 24k | 205.50 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.4 | $4.3M | 32k | 134.85 | |
| Celcuity (CELC) | 1.3 | $4.2M | 42k | 99.74 | |
| Disc Medicine (IRON) | 1.2 | $3.8M | 48k | 79.41 | |
| Ideaya Biosciences (IDYA) | 1.1 | $3.4M | 97k | 34.57 | |
| UnitedHealth (UNH) | 1.0 | $3.2M | 15k | 218.02 | |
| Compass Therapeutics (CMPX) | 1.0 | $3.1M | 584k | 5.37 | |
| Soleno Therapeutics (SLNO) | 0.9 | $2.9M | 63k | 46.30 | |
| Arcellx Common Stock (ACLX) | 0.9 | $2.7M | 42k | 65.20 | |
| Dexcom Com New (DXCM) | 0.8 | $2.6M | 40k | 66.37 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.7 | $2.3M | 1.2M | 1.99 | |
| Bicara Therapeutics (BCAX) | 0.6 | $1.9M | 111k | 16.83 | |
| Corbus Pharmaceuticals Hldgs (CRBP) | 0.3 | $873k | 107k | 8.14 | |
| Pyxis Oncology Common Stock (PYXS) | 0.2 | $710k | 617k | 1.15 |
